Compare VVOS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | AIDX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Medical Specialities | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 9.2M |
| IPO Year | 2020 | N/A |
| Metric | VVOS | AIDX |
|---|---|---|
| Price | $0.43 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 487.8K | 454.5K |
| Earning Date | 04-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,443,000.00 | N/A |
| Revenue This Year | $69.66 | N/A |
| Revenue Next Year | $48.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $0.38 | $0.51 |
| 52 Week High | $7.40 | $14.09 |
| Indicator | VVOS | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 36.13 |
| Support Level | $0.38 | $0.52 |
| Resistance Level | $0.55 | $0.70 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 31.76 | 41.45 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.